New Delhi / Hyderabad, India, December 16, 2021: Bharat Biotech, the first company in India to produce vaccine for Covid 19, Covaxin is to supply 2,00,000 doses to Vietnam. In a meeting with the Embassy of Vietnam for a one-on-one meeting with H.E Mr. Vuong Dinh Hue the President of the National Assembly os Socialist Republic of Vietnam, to discuss avenues of cooperation, supplies, and technology transfer possibilities in New Delhi on Thursday.
In the presence of distinguished dignitaries, Mrs. Suchitra Ella, Joint Managing Director of Bharat Biotech revealed that the Republic of Vietnam will receive 2,00,000 doses of Bharat Biotech COVAXIN. Covaxin now has a shelf life of 12 months after opening.
Ms. Suchitra Ella, Joint Managing Director of Bharat Biotech expressed it is an honour for us to serve the Republic of Vietnam in a humble manner and wish COVAXIN contribution will help boost up the country’s national vaccination program and recovery from the pandemic. We also like to thank H.E Mr. Vuong Dinh Hue of Vietnam for inviting us to meet and discuss opportunities for collaboration.
“We believe in vaccine equity, global public health, and having access to the vaccine is vital for national health, and I hope everyone in the Republic of Vietnam will take advantage of having access to the widely administered, safe and efficacious COVAXIN.” said Dr. Krishna Ella, Chairman and Managing Director of Bharat Biotech.
Bharat Biotech has completed Phase-2 and Phase-3 trials of COVAXIN for children in the age group 2 to 18 years. The data has been submitted to the Central Drugs Standard Control Organisation (CDSCO) and the final approval is awaited. On approval, children will also have access to COVAXIN.
